Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up

E.L. Kneepkens, J.C.C. Wei, M.T. Nurmohamed, K.J. Yeo, C.Y. Chen, I.E. van der Horst-Bruinsma, D. van der Kleij, T. Rispens, G. Wolbink, C.L.M. Krieckaert

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)396-401
JournalAnnals of the Rheumatic Diseases
Issue number2
Publication statusPublished - 2015

Cite this